Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Heron TherapeuticsY-mAbs TherapeuticsXencorLigand PharmaceuticalsPrestige Consumer Healthcare
Price Information
Current Price$14.71$43.20$31.94$111.91$37.56
52 Week RangeBuyBuyHoldBuyHold
Beat the Market™ Rank
Overall Score1.
Analysis Score4.
Community Score2.
Dividend Score0.
Ownership Score0.
Earnings & Valuation Score0.
Analyst Ratings
Consensus RecommendationBuyBuyHoldBuyHold
Consensus Price Target$38.11$44.60$42.60$169.00$66.83
% Upside from Price Target159.08% upside3.24% upside33.38% upside51.01% upside77.94% upside
Trade Information
Market Cap$1.33 billion$1.82 billion$1.83 billion$1.80 billion$1.83 billion
Average Volume2,075,667243,085479,766367,070529,212
Sales & Book Value
Annual Revenue$145.97 millionN/A$156.70 million$120.28 million$963.01 million
Price / Sales9.13N/A11.6214.931.95
CashflowN/AN/A$0.51 per share$5.99 per share$3.76 per share
Price / CashN/AN/A62.5218.6910.00
Book Value$4.48 per share$5.01 per share$10.46 per share$43.68 per share$23.30 per share
Price / Book3.28N/A3.052.561.61
Net Income$-204,750,000.00$-81,030,000.00$26.88 million$629.30 million$142.28 million
Trailing P/E RatioN/AN/AN/AN/A13.51
Forward P/E RatioN/AN/AN/A35.5311.96
P/E GrowthN/AN/AN/A$2.84$3.06
Net Margins-138.31%N/A-79.39%-55.63%14.77%
Return on Equity (ROE)-56.85%-64.21%-10.40%3.68%13.33%
Return on Assets (ROA)-43.05%-57.03%-9.24%2.03%4.35%
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt-to-Equity Ratio0.05%0.01%0.01%0.69%1.50%
Current Ratio4.53%12.79%8.92%40.65%2.44%
Quick Ratio4.17%12.79%8.92%40.29%1.67%
Ownership Information
Institutional Ownership PercentageN/A50.47%90.03%N/AN/A
Insider Ownership Percentage12.56%31.89%3.66%8.40%1.14%
Shares Outstanding90.64 million39.76 million57.01 million16.05 million50.09 million
Next Earnings Date8/3/2020 (Estimated)8/12/2020 (Estimated)8/4/2020 (Estimated)8/4/2020 (Estimated)8/6/2020 (Estimated)
OptionableOptionableNot OptionableOptionableOptionableOptionable

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.